Intellipharmaceutics International Inc IPCIQ

Healthcare Biotechnology

Intellipharmaceutics International Inc is a Canada-based pharmaceutical company engaged in the research, development and manufacture of controlled-release and targeted-release oral solid dosage drugs. Its Hypermatrix technology is a multidimensional controlled-release drug delivery platform that is applied to the development of a range of existing and new pharmaceuticals. Based on this technology platform, it has developed various drug delivery systems and a pipeline of products, and product candidates in various stages of development, in therapeutic areas that include neurology and cardiovascular. Its pipeline of products includes Rexista Oxycodone, Regabatin XR, Generic Focalin XR, Generic Effexor XR, Generic Protonix, Generic Glucophage XR, Generic Seroquel XR, Generic Lamictal XR, Generic Keppra XR, Generic Pristiq and Generic Ranexa. Its generic product candidates also include Trazodone hydrochloride extended-release tablets and Carvedilol phosphate extended-release capsules.

GREY:IPCIQ - Post by User

Intellipharmaceutics International Inc > Did you notice?

<< Previous

Bullboard Posts

Next >>

Comment by bigkaganon Jan 18, 2020 1:26am

124 Views

Post# 30568135

RE:RE:RE:Did you notice?

if FDA every time does what AdCom decides why do we need FDA at all, let AdCom issue all the drug permits, we'll save millions on all those FDA salaries, ha

<< Previous

Bullboard Posts

Next >>

A Look into the Future of Chronic Pain Management